Investor’s Toolkit: Key Ratios for Assessing Healthequity Inc (HQY)’s Performance

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

Healthequity Inc (NASDAQ: HQY) closed the day trading at $101.08 down -3.51% from the previous closing price of $104.76. In other words, the price has decreased by -$3.51 from its previous closing price. On the day, 1.49 million shares were traded.

Ratios:

For a better understanding of HQY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 30.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.88. For the most recent quarter (mrq), Quick Ratio is recorded 4.06 and its Current Ratio is at 4.06. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.52.

On March 25, 2025, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also lowered its target price recommendation from $120 to $115.

On December 04, 2024, Mizuho started tracking the stock assigning a Outperform rating and target price of $126.Mizuho initiated its Outperform rating on December 04, 2024, with a $126 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 06 ’25 when Kessler Jon sold 134,183 shares for $112.08 per share. The transaction valued at 15,038,655 led to the insider holds 253,510 shares of the business.

Kessler Jon sold 97,767 shares of HQY for $10,954,322 on Jun 06 ’25. The Former Director now owns 75,000 shares after completing the transaction at $112.05 per share. On Jun 06 ’25, another insider, Rosner Elimelech, who serves as the EVP, CHIEF TECHNOLOGY OFFICER of the company, sold 58,000 shares for $112.56 each. As a result, the insider received 6,528,434 and left with 75,689 shares of the company.

Valuation Measures:

As of this moment, Healthequity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 73.57, and their Forward P/E ratio for the next fiscal year is 22.92. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.03 while its Price-to-Book (P/B) ratio in mrq is 4.13.

Stock Price History:

Over the past 52 weeks, HQY has reached a high of $116.65, while it has fallen to a 52-week low of $65.01. The 50-Day Moving Average of the stock is 7.73%, while the 200-Day Moving Average is calculated to be 7.15%.

Shares Statistics:

A total of 86.71M shares are outstanding, with a floating share count of 84.10M. Insiders hold about 2.74% of the company’s shares, while institutions hold 108.10% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.